NCT02282059 2024-06-20The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine TumorsPfizerCompleted100 enrolled 13 charts